Copyright Reports & Markets. All rights reserved.

Global Cyclic Peptide Compounds Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Cyclic Peptide Compounds Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Natural Cyclic Peptide
    • 1.3.3 Synthetic Cyclic Peptide
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Cyclic Peptide Compounds Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Biopharmaceutical
    • 1.4.3 Environmental Protection
    • 1.4.4 Scientific Research
    • 1.4.5 Others
  • 1.5 Global Cyclic Peptide Compounds Market Size & Forecast
    • 1.5.1 Global Cyclic Peptide Compounds Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Cyclic Peptide Compounds Sales Quantity (2019-2030)
    • 1.5.3 Global Cyclic Peptide Compounds Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Bicycle Therapeutics
    • 2.1.1 Bicycle Therapeutics Details
    • 2.1.2 Bicycle Therapeutics Major Business
    • 2.1.3 Bicycle Therapeutics Cyclic Peptide Compounds Product and Services
    • 2.1.4 Bicycle Therapeutics Cyclic Peptide Compounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Bicycle Therapeutics Recent Developments/Updates
  • 2.2 Apellis Pharmaceuticals
    • 2.2.1 Apellis Pharmaceuticals Details
    • 2.2.2 Apellis Pharmaceuticals Major Business
    • 2.2.3 Apellis Pharmaceuticals Cyclic Peptide Compounds Product and Services
    • 2.2.4 Apellis Pharmaceuticals Cyclic Peptide Compounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Apellis Pharmaceuticals Recent Developments/Updates
  • 2.3 Merck
    • 2.3.1 Merck Details
    • 2.3.2 Merck Major Business
    • 2.3.3 Merck Cyclic Peptide Compounds Product and Services
    • 2.3.4 Merck Cyclic Peptide Compounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Merck Recent Developments/Updates
  • 2.4 Bachem
    • 2.4.1 Bachem Details
    • 2.4.2 Bachem Major Business
    • 2.4.3 Bachem Cyclic Peptide Compounds Product and Services
    • 2.4.4 Bachem Cyclic Peptide Compounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Bachem Recent Developments/Updates
  • 2.5 Novartis
    • 2.5.1 Novartis Details
    • 2.5.2 Novartis Major Business
    • 2.5.3 Novartis Cyclic Peptide Compounds Product and Services
    • 2.5.4 Novartis Cyclic Peptide Compounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Novartis Recent Developments/Updates
  • 2.6 Roche (Chugai Pharmabody Research)
    • 2.6.1 Roche (Chugai Pharmabody Research) Details
    • 2.6.2 Roche (Chugai Pharmabody Research) Major Business
    • 2.6.3 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Product and Services
    • 2.6.4 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Roche (Chugai Pharmabody Research) Recent Developments/Updates
  • 2.7 Biopharma PEG Scientific
    • 2.7.1 Biopharma PEG Scientific Details
    • 2.7.2 Biopharma PEG Scientific Major Business
    • 2.7.3 Biopharma PEG Scientific Cyclic Peptide Compounds Product and Services
    • 2.7.4 Biopharma PEG Scientific Cyclic Peptide Compounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Biopharma PEG Scientific Recent Developments/Updates
  • 2.8 Pfizer
    • 2.8.1 Pfizer Details
    • 2.8.2 Pfizer Major Business
    • 2.8.3 Pfizer Cyclic Peptide Compounds Product and Services
    • 2.8.4 Pfizer Cyclic Peptide Compounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Pfizer Recent Developments/Updates
  • 2.9 AstraZeneca
    • 2.9.1 AstraZeneca Details
    • 2.9.2 AstraZeneca Major Business
    • 2.9.3 AstraZeneca Cyclic Peptide Compounds Product and Services
    • 2.9.4 AstraZeneca Cyclic Peptide Compounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 AstraZeneca Recent Developments/Updates
  • 2.10 Eli Lilly
    • 2.10.1 Eli Lilly Details
    • 2.10.2 Eli Lilly Major Business
    • 2.10.3 Eli Lilly Cyclic Peptide Compounds Product and Services
    • 2.10.4 Eli Lilly Cyclic Peptide Compounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Eli Lilly Recent Developments/Updates
  • 2.11 GenScript Biotech
    • 2.11.1 GenScript Biotech Details
    • 2.11.2 GenScript Biotech Major Business
    • 2.11.3 GenScript Biotech Cyclic Peptide Compounds Product and Services
    • 2.11.4 GenScript Biotech Cyclic Peptide Compounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 GenScript Biotech Recent Developments/Updates

3 Competitive Environment: Cyclic Peptide Compounds by Manufacturer

  • 3.1 Global Cyclic Peptide Compounds Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Cyclic Peptide Compounds Revenue by Manufacturer (2019-2024)
  • 3.3 Global Cyclic Peptide Compounds Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Cyclic Peptide Compounds by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Cyclic Peptide Compounds Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Cyclic Peptide Compounds Manufacturer Market Share in 2023
  • 3.5 Cyclic Peptide Compounds Market: Overall Company Footprint Analysis
    • 3.5.1 Cyclic Peptide Compounds Market: Region Footprint
    • 3.5.2 Cyclic Peptide Compounds Market: Company Product Type Footprint
    • 3.5.3 Cyclic Peptide Compounds Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Cyclic Peptide Compounds Market Size by Region
    • 4.1.1 Global Cyclic Peptide Compounds Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Cyclic Peptide Compounds Consumption Value by Region (2019-2030)
    • 4.1.3 Global Cyclic Peptide Compounds Average Price by Region (2019-2030)
  • 4.2 North America Cyclic Peptide Compounds Consumption Value (2019-2030)
  • 4.3 Europe Cyclic Peptide Compounds Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Cyclic Peptide Compounds Consumption Value (2019-2030)
  • 4.5 South America Cyclic Peptide Compounds Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Cyclic Peptide Compounds Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Cyclic Peptide Compounds Sales Quantity by Type (2019-2030)
  • 5.2 Global Cyclic Peptide Compounds Consumption Value by Type (2019-2030)
  • 5.3 Global Cyclic Peptide Compounds Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Cyclic Peptide Compounds Sales Quantity by Application (2019-2030)
  • 6.2 Global Cyclic Peptide Compounds Consumption Value by Application (2019-2030)
  • 6.3 Global Cyclic Peptide Compounds Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Cyclic Peptide Compounds Sales Quantity by Type (2019-2030)
  • 7.2 North America Cyclic Peptide Compounds Sales Quantity by Application (2019-2030)
  • 7.3 North America Cyclic Peptide Compounds Market Size by Country
    • 7.3.1 North America Cyclic Peptide Compounds Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Cyclic Peptide Compounds Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Cyclic Peptide Compounds Sales Quantity by Type (2019-2030)
  • 8.2 Europe Cyclic Peptide Compounds Sales Quantity by Application (2019-2030)
  • 8.3 Europe Cyclic Peptide Compounds Market Size by Country
    • 8.3.1 Europe Cyclic Peptide Compounds Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Cyclic Peptide Compounds Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Cyclic Peptide Compounds Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Cyclic Peptide Compounds Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Cyclic Peptide Compounds Market Size by Region
    • 9.3.1 Asia-Pacific Cyclic Peptide Compounds Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Cyclic Peptide Compounds Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Cyclic Peptide Compounds Sales Quantity by Type (2019-2030)
  • 10.2 South America Cyclic Peptide Compounds Sales Quantity by Application (2019-2030)
  • 10.3 South America Cyclic Peptide Compounds Market Size by Country
    • 10.3.1 South America Cyclic Peptide Compounds Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Cyclic Peptide Compounds Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Cyclic Peptide Compounds Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Cyclic Peptide Compounds Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Cyclic Peptide Compounds Market Size by Country
    • 11.3.1 Middle East & Africa Cyclic Peptide Compounds Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Cyclic Peptide Compounds Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Cyclic Peptide Compounds Market Drivers
  • 12.2 Cyclic Peptide Compounds Market Restraints
  • 12.3 Cyclic Peptide Compounds Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Cyclic Peptide Compounds and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Cyclic Peptide Compounds
  • 13.3 Cyclic Peptide Compounds Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Cyclic Peptide Compounds Typical Distributors
  • 14.3 Cyclic Peptide Compounds Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Cyclic Peptide Compounds market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Cyclic Peptide Compounds market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Cyclic Peptide Compounds market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030
    Global Cyclic Peptide Compounds market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030
    Global Cyclic Peptide Compounds market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030
    Global Cyclic Peptide Compounds market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Cyclic Peptide Compounds
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Cyclic Peptide Compounds market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bicycle Therapeutics, Apellis Pharmaceuticals, Merck, Bachem, Novartis, Roche (Chugai Pharmabody Research), Biopharma PEG Scientific, Pfizer, AstraZeneca, Eli Lilly, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Cyclic Peptide Compounds market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Natural Cyclic Peptide
    Synthetic Cyclic Peptide
    Market segment by Application
    Biopharmaceutical
    Environmental Protection
    Scientific Research
    Others
    Major players covered
    Bicycle Therapeutics
    Apellis Pharmaceuticals
    Merck
    Bachem
    Novartis
    Roche (Chugai Pharmabody Research)
    Biopharma PEG Scientific
    Pfizer
    AstraZeneca
    Eli Lilly
    GenScript Biotech
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Cyclic Peptide Compounds product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Cyclic Peptide Compounds, with price, sales quantity, revenue, and global market share of Cyclic Peptide Compounds from 2019 to 2024.
    Chapter 3, the Cyclic Peptide Compounds competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Cyclic Peptide Compounds breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Cyclic Peptide Compounds market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Cyclic Peptide Compounds.
    Chapter 14 and 15, to describe Cyclic Peptide Compounds sales channel, distributors, customers, research findings and conclusion.

    Buy now